Dr. Ashraf I. Eskander, MD

Dr. Eskander practices at Miravilla Care Center in Cherry Valley, California.

Dr. Eskander's NPI, 1790756070, was assigned on January 27, 2006. Dr. Eskander graduated from Ain Shams University Faculty of Medicine in 1980. Dr. Eskander holds California license A48837.

Dr. Eskander's primary practice is Miravilla Care Center, at 9246 Avenida Miravilla, Cherry Valley, CA 92223 in Riverside County. The practice phone is (951) 845-3194.

Dr. Eskander's primary practice is Miravilla Care Center in Cherry Valley, California. Dmand AI also links Dr. Eskander to 1 physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eskander practices. Vendor and product names are available with a free account.

Hospitalist is Dr. Eskander's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Eskander's licenses on file in 2 states: California and New Jersey.

Dmand AI lists alzheimer's disease, aneurysm, anxiety, arthritis, asthma, atrial fibrillation and flutter, bladder disease and cardiomyopathy among the conditions Dr. Eskander treats.

CMS data shows 6,661 Medicare services from Dr. Eskander across 5 procedure codes in 2024, for 784 Medicare patients. Medicare paid $439,159 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 784 Medicare patients who saw Dr. Eskander in 2024. The largest group is 75 to 84, with 258 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 66% are also on Medicaid. Their average risk score is 2.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eskander's median patient age at 76, with 53% women.

In 2024, Dr. Eskander wrote 28,792 Medicare Part D claims for 759 patients. 82% of them were for generic drugs. CMS names the drug for 27,946 of them, across 265 drugs with 11 or more claims each, at $1,647,734 in total drug cost. In 2023, CMS named 29,472 claims across 274 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Eskander for performance year 2024, reported individually.

CMS Open Payments shows 7 general payments to Dr. Eskander from 6 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $35.

Dr. Eskander graduated from Ain Shams University Faculty of Medicine in 1980.

Dr. Eskander is in network with 5 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.